Cognitive Dysfunction in Chronic and Persistent Immune Thrombocytopenia

Part of paid clinical trials in Boston, Massachusetts.

Sponsor
Massachusetts General Hospital
Study ID
NCT06817395
Status
Recruiting
Apply to this trial

Conditions

  • Immune Thrombocytopenia

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

Individuals with immune thrombocytopenia (ITP) frequently report difficulties with attention and memory. The main question this study seeks to answer is: Do patients with ITP have evidence of cognitive impairment as detected by a cognitive function test battery? To address this issue, participants will take a cognitive function test and complete surveys on quality of life, fatigue, depression, and cognitive symptoms. The primary aim of the study is to evaluate for the presence and extent of cognitive impairment in patients with ITP. The study will also assess whether cognitive impairment in ITP is associated with patient-reported impacts on quality of life, fatigue, mood, and cognitive symptoms as well as clinical characteristics such as ITP disease and treatment history.

Key Dates

Start date
Sep 15, 2024
Status verified
Feb 2025
Primary completion
Sep 15, 2026
Completion
Sep 15, 2028

Study Design

Enrollment
100 participants (estimated)

Arms

  • Arm: Adults with chronic or persistent ITP

Primary Outcome Measure

Impairment of fluid cognition [ Time Frame: Baseline ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Massachusetts General HospitalBostonMassachusetts02114
Debbie C Jiang, MD
[email protected]
617-724-4000

Find similar trials in Boston, MA

By research site
Massachusetts General Hospital· Boston, MA

Related Studies